New cancer drug GEN1078 tested in small, Early-Stage trial
NCT ID NCT06771921
First seen Feb 01, 2026 · Last updated May 07, 2026 · Updated 10 times
Summary
This trial tested a new drug, GEN1078, in 3 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check for side effects and see how the body processes the drug. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Integral Oncologico Clara Campal
Madrid, Spain
-
Clinica Universidad de Navarra
Pamplona, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Hospital Universitary Fundacion Jimenez Diaz
Madrid, Spain
-
NEXT Oncology Madrid
Madrid, Spain
-
Righshospitalet (Copenhagen University Hospital)
Copenhagen, Denmark
Conditions
Explore the condition pages connected to this study.